• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[关于给予含3'-甲基-4-二甲基氨基偶氮苯饮食诱导大鼠肝癌发生过程中肝脏醛缩酶同工酶变化的生化及免疫组化研究]

[Biochemical and immunohistochemical studies on alteration of aldolase isozymes in rat liver in the process of hepatocarcinogenesis by administration of a diet containing 3'-methyl-4-dimethylaminoazobenzene].

作者信息

Nishikawa S

机构信息

Third Department of Internal Medicine, Hokkaido University School of Medicine, Sapporo, Japan.

出版信息

Hokkaido Igaku Zasshi. 1989 Jul;64(4):440-9.

PMID:2511129
Abstract

Aldolase A, B, and C were determined in rat liver and serum by radioimmunoassay (RIA) in order to evaluate the alteration of these isozymes in the process of hepatocarcinogenesis induced by 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB), and the immunohistochemical technique was also used for the analysis of localization of aldolase isozymes. Aldolase A was increased in cancer tissues of 3'-Me-DAB induced hepatoma, whereas aldolase B was decreased in the same tissues according to both RIA and the immunohistochemical technique. During the promotion stage of hepatocarcinogenesis, the cells in hyperplastic nodules, which are known as preneoplastic lesions, were stained for aldolase A. Aldolase C was slightly increased in cancer tissues by RIA, suggesting the increase of A-C hybrid like A3C which was demonstrated by the electrophoretic method. Serum aldolase A levels were not significantly elevated in rats with liver cancer in comparison to rats with non-cancer.

摘要

采用放射免疫分析法(RIA)测定大鼠肝脏和血清中的醛缩酶A、B和C,以评估3'-甲基-4-二甲基氨基偶氮苯(3'-Me-DAB)诱导肝癌发生过程中这些同工酶的变化,同时采用免疫组织化学技术分析醛缩酶同工酶的定位。根据RIA和免疫组织化学技术,3'-Me-DAB诱导的肝癌癌组织中醛缩酶A增加,而同一组织中的醛缩酶B减少。在肝癌发生的促进阶段,增生性结节(即癌前病变)中的细胞被醛缩酶A染色。通过RIA检测发现癌组织中醛缩酶C略有增加,提示电泳法所证实的A-C杂交体如A3C增加。与非癌大鼠相比,肝癌大鼠血清醛缩酶A水平无显著升高。

相似文献

1
[Biochemical and immunohistochemical studies on alteration of aldolase isozymes in rat liver in the process of hepatocarcinogenesis by administration of a diet containing 3'-methyl-4-dimethylaminoazobenzene].[关于给予含3'-甲基-4-二甲基氨基偶氮苯饮食诱导大鼠肝癌发生过程中肝脏醛缩酶同工酶变化的生化及免疫组化研究]
Hokkaido Igaku Zasshi. 1989 Jul;64(4):440-9.
2
[Studies on aldolase isozymes in liver tissue in carcinogenesis induced by azo dyes].
Igaku Kenkyu. 1967 Dec;37(7):824-44.
3
Inhibitory effect of fumaric acid on 3-methyl-4'-(dimethylamino)-azobenzene-induced hepatocarcinogenesis in rats.富马酸对3-甲基-4'-(二甲基氨基)-偶氮苯诱导的大鼠肝癌发生的抑制作用。
J Natl Cancer Inst. 1983 Oct;71(4):855-7.
4
[Immunoreactivities and messenger RNA expression of aldolase A and B in human hepatoma cell lines].人肝癌细胞系中醛缩酶A和B的免疫反应性及信使核糖核酸表达
Hokkaido Igaku Zasshi. 1994 Sep;69(5):1232-43.
5
Irreversible fixation of increased level of muscle type aldolase activity appearing in rat liver in the early stage of hepatocarcinogenesis.肝癌发生早期大鼠肝脏中出现的肌肉型醛缩酶活性水平升高的不可逆固定。
Cancer Res. 1970 Mar;30(3):743-52.
6
Biochemical and clinical studies of aldolase isozymes in human cancer.人类癌症中醛缩酶同工酶的生化与临床研究。
Isozymes Curr Top Biol Med Res. 1983;11:183-95.
7
Localization of fetal aldolases during early stages of azo-dye hepatocarcinogenesis in rat.
Biochem Biophys Res Commun. 1980 Jan 29;92(2):591-7. doi: 10.1016/0006-291x(80)90374-5.
8
[Experimental study on aldolase isozyme during the development of hepatoma in the rat (author's transl)].大鼠肝癌发生过程中醛缩酶同工酶的实验研究(作者译)
Hokkaido Igaku Zasshi. 1976 Mar;51(2):129-43.
9
Enhancement of hepatocarcinogenesis by sorbitan fatty acid ester, a liver pyruvate kinase activity-reducing substance.
J Natl Cancer Inst. 1985 Aug;75(2):381-4.
10
Changes of aldolase A and B messenger RNA levels in rat liver during azo-dye-induced hepatocarcinogenesis.偶氮染料诱导大鼠肝癌发生过程中肝脏中醛缩酶A和B信使RNA水平的变化
Biochem Biophys Res Commun. 1984 Oct 30;124(2):337-43. doi: 10.1016/0006-291x(84)91558-4.